← Back to Search

Reproductive Health Program for Cancer Patients (EROS Trial)

N/A
Waitlist Available
Led By Ashlesha Patel
Research Sponsored by Eastern Cooperative Oncology Group
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients not currently on hormonal contraception with the presence of menses in the past 6 months
Pre-menopausal patients within the reproductive age range of 15-55 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 3, 6, 12, 24 months
Awards & highlights

EROS Trial Summary

This trial looks at a program to help cancer patients understand and manage their fertility risks.

Who is the study for?
This trial is for pre-menopausal women aged 15-55 with a new cancer diagnosis, including those pregnant or with DCIS. Eligible participants must have cognitive ability to engage in the study and meet specific hormonal criteria. Women who've started chemo, radiation, endocrine therapy, or had certain sterilizing surgeries can't join.Check my eligibility
What is being tested?
The study evaluates a reproductive health program designed to help female cancer patients understand and manage reproductive risks while pursuing their fertility goals. It includes standard practices plus training modules and referral development tailored to each patient's needs.See study design
What are the potential side effects?
Since this trial involves educational programs rather than medical treatments, there are no direct side effects related to drugs or procedures. However, learning about fertility options may cause emotional or psychological impact.

EROS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am not on birth control and have had a period in the last 6 months.
Select...
I am a pre-menopausal woman aged between 15 and 55.

EROS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 3, 6, 12, 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 3, 6, 12, 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of Patients With Appropriate Reproductive Health Management
Secondary outcome measures
Associations Between Clinical and Demographic Factors and Adequacy of Reproductive Health Care Management
Difference in Rating Between Patients and Their Clinicians in Importance of Fertility Maintenance
The Changes in Reproductive Health Status From Baseline to 3 Months
Other outcome measures
Levels of Endocrine Markers of Fertility
Sexual Function Score by Patient-Reported Outcomes Measurement Information System (PROMIS)

EROS Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Arm B (reproductive health program)Experimental Treatment1 Intervention
Patients undergo reproductive health program comprising didactics, reproductive health assessment and navigating algorithm, and network development.
Group II: Arm A (no intervention)Active Control1 Intervention
Patients undergo usual standard practice related to reproductive health.

Find a Location

Who is running the clinical trial?

Eastern Cooperative Oncology GroupLead Sponsor
268 Previous Clinical Trials
150,396 Total Patients Enrolled
ECOG-ACRIN Cancer Research GroupLead Sponsor
115 Previous Clinical Trials
176,388 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,609 Previous Clinical Trials
40,915,212 Total Patients Enrolled

Media Library

Arm B (reproductive health program) Clinical Trial Eligibility Overview. Trial Name: NCT01806129 — N/A
Cancer Research Study Groups: Arm A (no intervention), Arm B (reproductive health program)
Cancer Clinical Trial 2023: Arm B (reproductive health program) Highlights & Side Effects. Trial Name: NCT01806129 — N/A
Arm B (reproductive health program) 2023 Treatment Timeline for Medical Study. Trial Name: NCT01806129 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What qualifications must a candidate satisfy to join this experiment?

"This study seeks 434 individuals affected by malignant neoplasms aged between 15 and 55. To qualify for the trial, participants must meet these criteria."

Answered by AI

Can adults aged 18 and over participate in this trial?

"This medical study is recruiting individuals aged between 15 and 55 years old."

Answered by AI

How many locations are participating in the research trial?

"This clinical trial is taking place in over 100 sites, including Robbinsdale, Bemidji and Columbus. For participants' convenience it's recommended to pick the nearest location to reduce travel requirements."

Answered by AI

Are there any opportunities to participate in this clinical trial presently?

"Inaccurate. Clinicaltrials.gov's records reveal that this medical experiment, first posted on July 14th 2016 and last edited October 5 2022, is not currently recruiting individuals for participation. Nevertheless, there are still 2391 other trials which need volunteers right now."

Answered by AI
~51 spots leftby Mar 2025